News Digging > Lifestyle > Pfizer Vaccine Candidate Gains FDA Support for RSV in Older Adults
Pfizer Vaccine Candidate Gains FDA Support for RSV in Older Adults
Pfizer Vaccine Candidate Gains FDA Support for RSV in Older Adults,Pfizer Inc. (NYSE: PFE) announced today that the U.S. Food and Drug Administration’s (FDA) Vaccines and Related Biological Products Advisory Committee

Pfizer Vaccine Candidate Gains FDA Support for RSV in Older Adults

Pfizer Inc. (NYSE: PFE) announced today that the U.S. Food and Drug Administration’s (FDA) Vaccines and Related Biological Products Advisory Committee